Dr. Michael Bentov Gutman, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 21 N Main St, West Hartford, CT 06107 Phone: 860-236-3911 |
Nike Itohan Kubeyinje, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 785 Farmington Avenue, West Hartford, CT 06119 Phone: 860-523-4100 Fax: 860-523-1462 |
Ms. Heather Lea Dodds, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1028 Boulevard, #230, West Hartford, CT 06119 Phone: 860-836-5961 |
Dr. Jody R Lewinter, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 336 North Main Street, West Hartford, CT 06117 Phone: 860-232-4891 Fax: 860-263-1016 |
Dr. Matthew Ledford, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 148 Dover Rd, West Hartford, CT 06119 Phone: 714-414-7005 |
Herbert William Felsenfeld, M.D., PH.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 275 Steele Rd, B304, West Hartford, CT 06117 Phone: 860-523-1189 |
News Archive
Without congressional action this week on a tax "extenders" and jobs bill, a number of benefits, including a subsidy for COBRA health insurance benefits for newly laid-off workers, will expire.
BioSante Pharmaceuticals, Inc. today announced that it will present a LibiGel clinical trial update at the 21st Annual Meeting of The North American Menopause Society (NAMS) being held from October 6-9, 2010 at the Sheraton Chicago Hotel & Towers in Chicago, Illinois.
New guidelines issued by the American Gastroenterological Association (AGA) support the use of radiofrequency ablation (RFA) to remove precancerous cells in patients with Barrett's esophagus, a condition most commonly caused by chronic acid reflux, or GERD. Barrett's esophagus is the leading cause of esophageal cancer and affects an estimated two million Americans.
Ampio Pharmaceuticals, Inc., a biopharmaceutical company conducting clinical trials on its three lead drugs, licensing distribution of these drugs and engaged in further drug development, today announced that it has received notice of allowance from the US Patent Office of an additional patent that complements and expands its anti inflammatory patent portfolio for its lead drug Ampion.
› Verified 9 days ago